Partners in Discovery
Partners in Discovery
Vanderbilt-Ingram Cancer Center
Vanderbilt-Ingram Cancer Center is at the forefront of new discoveries that help us prevent, find, treat, manage and cure cancer. But we can't make these discoveries alone. Our patients, caregivers, community leaders, donors, volunteers, and educators contribute their insight, time, and passion to advancing the discoveries that lead us closer to a cure.
No matter how cancer has touched your life, you are a key partner in our efforts to save lives and improve the quality of life for those with cancer.
Harnessing the power of
science for our patients
Our doctors and researchers are turning today's
scientific discoveries into tomorrow's treatments.
Learn more about our research programs and initiatives.
Proven Track Record
A leader in research, innovation and treatment. We are one of 50 National Cancer Institute-designated Comprehensive Cancer Centers, dedicated to an integrated and patient-focused approach.
Patients, Partners, Progress
Our patients and families are our most important partners in discovery – and the motivation behind our efforts to advance research and improve cancer care.
Read their stories from Momentum magazine.
Cancer Center News
Latest news about our research, patient care programs, outreach and educational events.
Therapy animals' impact on children with cancer studied
Mary Jo Gilmer, PhD, recently received a grant from nonprofit Human Animal Bond Research Institute (HABRI) for a pilot program investigating the health benefits of human-animal interactions (HAIs) in reducing suffering of children with cancer undergoing debilitating treatments.
Asian nations in early tobacco epidemic: study
Asian countries are in the early stages of a tobacco smoking epidemic with habits mirroring those of the United States from past decades, setting the stage for a spike in future deaths from smoking-related diseases.
Researchers putting the brakes on lethal childhood cancer
A recent study suggests that blocking the MYC protein could be “unexpectedly effective” in treating malignant rhabdoid tumor (MRT) is one of the most aggressive and lethal childhood cancers.
Team explores fungal infection quandary in lung cancer screenings
A recent study by Vanderbilt investigators revealed that histoplasmosis - a fungal infection that creates cancer-mimicking lesions in the lungs - is prevalent beyond previously identified regions of the United States.
New guidelines recommend colonoscopy at 45
The American Cancer Society now recommends people at average risk be screened for colorectal cancer via colonoscopy, or another method, starting at age 45, rather than at age 50.
